Maytag mail-order pharmacy costs cut by 90% after re-emphasis of community pharmacy in Newton, Iowa.
Executive Summary
MAYTAG MONTHLY MAIL-SERVICE Rx BILLS ARE ABOUT $4,000, down from approximately $50,000 before the company eliminated its mail-order pharmacy program as part of a patient-focused pharmaceutical care plan, Maytag Benefits Consultant William Ward told the Ohio Pharmaceutical Seminar in Columbus April 22. Ward labeled the company's decision to contract with a mail-order firm in 1986 "without consulting our pharmacy community" a "mistake." With the de-emphasis of mail-order, "we have a single pharmacy that's managing [an] individual's care, which really makes a lot of sense, and in hindsight we should have gone to the pharmacy community in 1986," Ward said.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth